| 000 | 01855 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517171035.0 | ||
| 264 | 0 | _c20191016 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a1873-2402 | ||
| 024 | 7 |
_a10.1016/j.biopsych.2017.06.032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSlivicki, Richard A | |
| 245 | 0 | 0 |
_aPositive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence. _h[electronic resource] |
| 260 |
_bBiological psychiatry _c11 2018 |
||
| 300 |
_a722-733 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzamides _xpharmacology |
| 650 | 0 | 4 |
_aBenzodioxoles _xpharmacology |
| 650 | 0 | 4 |
_aBenzoxazines _xpharmacology |
| 650 | 0 | 4 |
_aCannabinoid Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aCarbamates _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperalgesia _xchemically induced |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aNeuralgia _xetiology |
| 650 | 0 | 4 | _aPaclitaxel |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xagonists |
| 650 | 0 | 4 | _aReward |
| 700 | 1 | _aXu, Zhili | |
| 700 | 1 | _aKulkarni, Pushkar M | |
| 700 | 1 | _aPertwee, Roger G | |
| 700 | 1 | _aMackie, Ken | |
| 700 | 1 | _aThakur, Ganesh A | |
| 700 | 1 | _aHohmann, Andrea G | |
| 773 | 0 |
_tBiological psychiatry _gvol. 84 _gno. 10 _gp. 722-733 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopsych.2017.06.032 _zAvailable from publisher's website |
| 999 |
_c27480874 _d27480874 |
||